Provided by Tiger Fintech (Singapore) Pte. Ltd.

Passage Bio, Inc.

0.4063
+0.02616.86%
Post-market: 0.40630.00000.00%18:59 EDT
Volume:361.90K
Turnover:149.81K
Market Cap:25.25M
PE:-0.40
High:0.4387
Open:0.3802
Low:0.3802
Close:0.3802
Loading ...

Passage Bio Inc. Reports Q1 2025 Results: Net Loss Narrows to $15.4M, EPS Improves to $0.25

Reuters
·
13 May

Passage Bio Inc - Cash Runway Extended Into 1Q 2027

THOMSON REUTERS
·
13 May

Passage Bio Q1 Income From Operations USD -16.459 Million

THOMSON REUTERS
·
13 May

Passage Bio Inc expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
09 May

Major Stakeholder Makes a Big Move with Passage Bio Shares!

TIPRANKS
·
25 Apr

Major Shareholder Orbimed Advisors Makes a Bold Move with Passage Bio Stock!

TIPRANKS
·
18 Apr

Passage Bio (PASG) Upgraded to Buy: Here's What You Should Know

Zacks
·
08 Mar

Analysts Offer Insights on Healthcare Companies: Ventyx Biosciences (VTYX), Black Diamond Therapeutics (BDTX) and Passage Bio (PASG)

TIPRANKS
·
07 Mar

Chardan Cuts Price Target on Passage Bio to $6 From $7, Keeps Buy Rating

MT Newswires Live
·
05 Mar

U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott International

Reuters
·
05 Mar

Passage Bio Inc : Chardan Capital Markets Cuts Target Price to $6 From $7

THOMSON REUTERS
·
05 Mar

Passage Bio Is Maintained at Buy by Chardan Capital

Dow Jones
·
05 Mar

Passage Bio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
05 Mar

Passage Bio Reports 2024 Financial Results and Program Advances

TIPRANKS
·
04 Mar

BRIEF-Passage Bio Reports Fourth Quarter and Full Year 2024 Results

Reuters
·
04 Mar

Passage Bio FY Income From Operations USD -70.4 Million

THOMSON REUTERS
·
04 Mar

Passage Bio Inc Q4 Shr View $-0.20 -- Lseg Ibes Data

THOMSON REUTERS
·
04 Mar

Passage Bio Inc - Net Loss $12.7 Million, or $0.20 per Basic and Diluted Share for Q4 2024

THOMSON REUTERS
·
04 Mar

Passage Bio Inc - Extended Cash Runway Into 1Q 2027

THOMSON REUTERS
·
04 Mar

Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights

GlobeNewswire
·
04 Mar